Hoxworth Blood Center honored by City of Cincinnati leadership for 85 years of serving the greater Cincinnati community
Hoxworth Blood Center, University of Cincinnati was honored with a resolution by City of Cincinnati leadership at City Hall on January 31, 2024 for Hoxworth’s 85 years of dedicated service to the greater Cincinnati community.
Hoxworth Blood Center celebrated their 85th anniversary on December 10, 2023 and is currently the oldest operating blood center in the nation.
Hoxworth is the sole supplier of blood products to more than 30 hospitals and medical centers across 18 counties in Ohio, Kentucky, and Indiana.
Hoxworth Blood Center would like to thank City of Cincinnati leadership, including Mayor Aftab Pureval and Vice-Mayor Jan Michelle Lemon-Kearney, as well as blood recipient and Hoxworth advocate, Sister Keli, for spreading awareness on blood donation and continuously supporting Hoxworth's mission in Saving Lives Close to Home.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.